Mika Grasso
CIK: 0002109231
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (0 total)
2 Form 3 filings on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 2 Form 3 filings on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Grasso Mika
Grasso Mika (SEC CIK 0002109231) files insider reports with the SEC as Director of BioRestorative Therapies, Inc. (BRTX) and Director of Nuwellis, Inc. (NUWE).
Signal8 holds 2 ownership filings by Grasso Mika, all Form 3s, filed between Feb 11, 2026 and Jun 18, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Grasso Mika's filings is in MELVILLE, NY.
Other insiders filing for BioRestorative Therapies, Inc. (BRTX)
- Randhawa Esha, Director
- Dhaliwal Jatinder, Director
- Field Katharyn, Director
- Silva Francisco, VP of Research and Development
- ALSTODT LANCE, President, CEO, COB
- Rosa David A, Director